<DOC>
	<DOC>NCT01016964</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 12 beam model for androgenetic alopecia in females when treatment is applied as directed.</brief_summary>
	<brief_title>Treatment of Androgenetic Alopecia in Females, 12 Beam</brief_title>
	<detailed_description>This is a randomized double-blind, sham controlled clinical study, evaluating changes in terminal hair count in the evaluation zone having evidence of androgenetic alopecia (miniaturized hair). The trial with 63 female subjects, who have been diagnosed with androgenetic alopecia, who are between 25 and 60 years of age, have Fitzpatrick Skin Types I-IV, with classifications of Ludwig I-4, II-1, II-2, or frontal, have active hair loss within the last 12 months. Subjects will use the device on three non-concurring days a week as directed per device for 26 weeks duration. Initial efficacy endpoint for each subject will be assessed at visit 4 (week 16). Safety analysis will be assessed based on the reports of adverse events during study.</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<criteria>Diagnosis of androgenetic alopecia Fitzpatrick Skin types IIV Ludwig I4, II1, II2, or frontal Active hair loss within last 12 months Photosensitivity to laser light Malignancy in the target area Pregnancy Lactating females</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Androgenetic Alopecia</keyword>
	<keyword>Hair Loss</keyword>
	<keyword>Female Pattern Baldness</keyword>
</DOC>